Ficolin-2 promoter polymorphism is associated with ficolin-2 concentrations, the AGGG haplotype contributes to the prevention of HBV infection and liver cancer, and AAAG is associated with higher serum ficolin-2 levels (Hoang et al., 2011). This evidence concerns the gene FCN2 and liver cancer.